Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal recessive mutations in ALOX12B, encoding 12R-lipoxygenase (12R-LOX), cause non-bullous congenital ichthyosiform erythroderma (NBCIE), a disorder marked by generalized scaling and erythroderma (HP:0000951, HP:0000961). The gene–disease relationship has been validated over >20 years and meets criteria for a Definitive association.
Genetic studies have identified biallelic ALOX12B variants in multiple cohorts, comprising >64 probands across >19 unrelated families (6 families: [PMID:11773004]; 17 families: [PMID:16116617]; 19 families: [PMID:19131948]). Segregation analysis confirms autosomal recessive inheritance in 19 affected relatives.
The variant spectrum includes >25 missense, >10 nonsense, frameshift indels and splice-site mutations, with no recurrent founder alleles described. A prototypical pathogenic change is c.1294C>T (p.Arg432Ter), introducing a premature termination codon.
In vitro assays in E. coli and COS-7 cells demonstrate that both missense and truncating ALOX12B mutations abolish 12R-LOX activity and disrupt hepoxilin synthesis, consistent with loss of function ([PMID:15629692]).
Alox12b knockout (‘mummy’) mice exhibit perinatal lethality, epidermal barrier defects and hyperkeratosis that recapitulate human NBCIE, further supporting causality ([PMID:17429434]).
No conflicting evidence has been reported. Convergent genetic, biochemical and animal model data establish ALOX12B LOF as the basis of NBCIE. Key take-home: Biallelic ALOX12B loss-of-function mutations underlie autosomal recessive NBCIE via impaired epidermal lipid metabolism, informing molecular diagnosis and exploration of lipid-based therapies.
Gene–Disease AssociationDefinitive
Genetic EvidenceStrongAutosomal recessive segregation in 19 relatives; >64 probands harboring >25 missense, >10 nonsense, frameshift and splice variants ([PMID:11773004]; [PMID:16116617]; [PMID:19131948]) Functional EvidenceModerateIn vitro LOX assays show complete loss of enzymatic activity ([PMID:15629692]); knockout mouse recapitulates human phenotype ([PMID:17429434]) |